Alopecia areata after ChAdOx1 nCoV-19 vaccine (Oxford/AstraZeneca): a potential triggering factor?

Essam, Reham; Ehab, Rana; Al-Razzaz, Radwa; Khater, Maha W; Moustafa, Emad A

Essam, Reham; Ehab, Rana; Al-Razzaz, Radwa; Khater, Maha W; Moustafa, Emad A.

Essam R; Dermatology, Venereology and Andrology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
Ehab R; Dermatology, Venereology and Andrology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
Al-Razzaz R; General Dermatology Department, Cairo Hospital for Dermatology and Venereology (Al-Haud Al-Marsoud), Cairo, Egypt.
Khater MW; Medical Microbiology and Immunology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
Moustafa EA; Tropical medicine Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt.

J Cosmet Dermatol ; 20(12): 3727-3729, 2021 Dec.

Article in English | MEDLINE | ID: covidwho-1438022

Subject(s)

Alopecia Areata; COVID-19; Alopecia Areata/chemically induced; Alopecia Areata/drug therapy; Humans; SARS-CoV-2

Keywords

COVID-19; ChAdOx1 nCoV-19 vaccine; SARS-CoV-2; hair falling

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Alopecia Areata / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: J Cosmet Dermatol Journal subject: Dermatology Year: 2021 Document Type: Article Affiliation country: Jocd.14459

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google